Seattle, Washington
United States
24
2014-06-05
11
2015-04-14
These are the the leading inventors for applications assigned to Emergent Product Development Seattle, LLC:
Emergent Product Development Seattle, LLC based in Seattle, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION
#2 | 2014-06-05SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION
#3 | 2014-05-22SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION
#4 | 2014-05-08SINGLE-CHAIN MULTIVALENT BINDING PROTEINS EFFECTOR FUNCTION
#5 | 2014-03-13B-CELL REDUCTION USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES
#6 | 2013-12-19SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION
#7 | 2013-08-01CD3 IMMUNOTHERAPEUTICS AND USES THEREOF
#8 | 2013-07-25TCR Complex Immunotherapeutics
#9 | 2013-06-06 ✅ Patent 9,005,612 granted on 2015-04-14Binding domain-immunoglobulin fusion proteins
#10 | 2013-05-23Heterodimer Binding Proteins and Uses Thereof
#11 | 2013-04-18Polypeptide Heterodimers and Uses Thereof
#12 | 2013-04-11RON Binding Constructs and Methods of Use Thereof
#13 | 2012-08-23 ✅ Patent 8,853,366 granted on 2014-10-07Binding domain-immunoglobulin fusion proteins
#14 | 2012-02-09 ✅ Patent 8,409,577 granted on 2013-04-02Single chain multivalent binding proteins with effector function
#15 | 2011-10-20 ✅ Patent 8,383,106 granted on 2013-02-26Materials and methods for improved immunoglycoproteins
#16 | 2011-09-15BINDING DOMAIN-IMMUNOGLOBULIN FUSION PROTEINS
#17 | 2011-09-08TCR Complex Immunotherapeutics
#18 | 2011-07-14 ✅ Patent 8,333,966 granted on 2012-12-18CD37 immunotherapeutics and uses thereof
#19 | 2011-06-16 ✅ Patent 8,632,774 granted on 2014-01-21Antagonists of IL-6
#20 | 2011-05-05 ✅ Patent 8,188,237 granted on 2012-05-29Binding domain-immunoglobulin fusion proteins
#21 | 2011-04-21 ✅ Patent 8,197,810 granted on 2012-06-12Binding domain-immunoglobulin fusion proteins
#22 | 2010-02-11 ✅ Patent 8,147,835 granted on 2012-04-03Binding domain-immunoglobulin fusion proteins
#23 | 2009-11-05 ✅ Patent 9,101,609 granted on 2015-08-11CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
#24 | 2005-09-15 ✅ Patent 8,106,161 granted on 2012-01-31Binding domain-immunoglobulin fusion proteins
Also check out Emergent Product Development Seattle, LLC's (Seattle, United States) applicant profile with 1 patent applications submitted.
17545 ⎘